Proceedings of the National Academy of Sciences · 2019 · 37 citations · 26 references
Life SciencesImmunologyNeuroscienceAutoimmunityInflammationNeuroimmunologyAutoimmune Disease PathogenesisAutoimmune DiseasesCentral Nervous System ImmunityHelper T Cell SubsetsNeuroinflammationT Cell ActivationAcute NeuroinflammationAntigen Presenting CellsExperimental Autoimmune EncephalomyelitisNaive T CellsPathogenic T Helper Cell DifferentiationProlactin BiosynthesisProlactin Immune RegulationT Helper Cells
Significance We have previously demonstrated that induction of pathogenic eomesodermin-positive CD4 + T cells (Eomes + T helper [Th] cells) is associated with transition from an acute stage to a later stage of experimental autoimmune encephalomyelitis (EAE). In the late phase of EAE, B cells and non-B cell antigen-presenting cells (APCs) recruited to the central nervous system strikingly up-regulate prolactin (PRL). The PRL-producing APCs have the potential to promote generation of Eomes + Th cells from naïve T cells in an MHC class II-restricted manner, and therapies inhibitory for PRL production suppress the induction of Eomes + Th cells and ameliorate clinical signs of EAE. Our study highlights the unexpected role of extrapituitary PRL in the development of persistent neuroinflammation.
26
TM4: A Free, Open-Source System for Microarray Data Management and Analysis
A Saeed, Vasily Sharov, Joseph White et al. · BioTechniques · 2003 · 5K citations · Full text
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text
Life Sciences, Immunology, Neurology +17